Dechra Pharmaceuticals plc 15.4% Potential Upside Indicated by Jefferies International

Broker Ratings
[shareaholic app="share_buttons" id_name="post_below_content"]

Dechra Pharmaceuticals plc with EPIC/TICKER (LON:DPH) had its stock rating noted as ‘Reiterates’ with the recommendation being set at ‘BUY’ today by analysts at Jefferies International. Dechra Pharmaceuticals plc are listed in the Health Care sector within UK Main Market. Jefferies International have set their target price at 3515 GBX on its stock. This now indicates the analyst believes there is a possible upside of 15.4% from the opening price of 3046 GBX. Over the last 30 and 90 trading days the company share price has increased 190 points and increased 302 points respectively. The 1 year high stock price is 3090 GBX while the year low stock price is currently 2030 GBX.

Dechra Pharmaceuticals plc has a 50 day moving average of 2,886.11 GBX and a 200 day moving average of 2,792.18. There are currently 108,010,960 shares in issue with the average daily volume traded being 332,518. Market capitalisation for LON:DPH is £3,261,536,762 GBP.

Twitter
LinkedIn
Facebook
Email
Reddit
Telegram
WhatsApp
Pocket
Find more news, interviews, share price & company profile here for:

      Search

      Search